Tuberculosis

FHI 360 works to enhance the capacity of national tuberculosis (TB) programs, local nongovernmental organizations, local communities and private for-profit service providers to address the challenges of TB at national, regional, district and community levels. Our programs are designed to strengthen the delivery of services for the prevention, diagnosis, treatment and provision of follow-up care for people affected by TB, while improving patient access to high-quality TB services. We give priority to implementing the Stop TB Strategy, a global plan to reduce the burden of TB by 2015 and to eliminate TB as a public health problem by 2050.

In addition to our programmatic work, FHI 360 develops TB research capacity in settings with a high TB burden, such as Brazil, China, India and South Africa. That work, which is sponsored by the U.S. National Institutes of Health and co-funded by host governments, will yield more rapid innovations in TB diagnosis, treatment and prevention.

GLOBAL EXPERTISE AND LEADERSHIP

FHI 360 provides technical, managerial and operational assistance to programs throughout the world. We assist in-country TB programs by building local capacity in a wide range of technical areas:

Enhanced direct observation of treatment, short-course (DOTS) strategy through quality-assured bacteriology
Community-based direct observation of treatment
Collaboration and integration of services for TB and HIV
TB services in prisons
Infection control
Laboratory procedures, including deployment of new technologies
Multidrug-resistant TB
Health systems strengthening
Universal access to TB services
Tools and guidelines

You are here

Tuberculosis